Selected research
Industry Growth & Trends
Global RNA Stabilizers Industry Growth and Trends Forecast to 2032
Market perspective
The global RNA Stabilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of RNA Stabilizers include Yeasen, YaJi Biological, NCM Biotech, Thermo Fisher Scientific, Vazyme, Merck, Maokangbio, Beyotime and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global RNA Stabilizers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The RNA Stabilizers market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RNA Stabilizers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RNA Stabilizers.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global RNA Stabilizers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
RNA Stabilizers Market by Company
Yeasen
YaJi Biological
NCM Biotech
Thermo Fisher Scientific
Vazyme
Merck
Maokangbio
Beyotime
Zymo Research
Takara Bio
SRL
Omega Bio-Tek
NZYtech
New England Biolabs
Genetix Biotech Asia
G-Biosciences
Dutscher
BioEntist
RNA Stabilizers Segment by Type
Solid Phase Stabilizers
Spray or Coating-Based Stabilizers
Solution-Based Stabilizers
RNA Stabilizers Segment by Application
Molecular Biology
Genomics
RNA Stabilizers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Stabilizers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Stabilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of RNA Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Phase Stabilizers
- Spray or Coating-Based Stabilizers
- Solution-Based Stabilizers
Applications
- Molecular Biology
- Genomics
Companies covered
- Yeasen
- YaJi Biological
- NCM Biotech
- Thermo Fisher Scientific
- Vazyme
- Merck
- Maokangbio
- Beyotime
- Zymo Research
- Takara Bio
- SRL
- Omega Bio-Tek
- NZYtech
- New England Biolabs
- Genetix Biotech Asia
- G-Biosciences
- Dutscher
- BioEntist
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global RNA Stabilizers Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global RNA Stabilizers Sales Estimates and Forecasts (2021-2032)
- 1.3 RNA Stabilizers Market by Type
- 1.3.1 Solid Phase Stabilizers
- 1.3.2 Spray or Coating-Based Stabilizers
- 1.3.3 Solution-Based Stabilizers
- 1.4 Global RNA Stabilizers Market Size by Type
- 1.4.1 Global RNA Stabilizers Market Size Overview by Type (2021-2032)
- 1.4.2 Global RNA Stabilizers Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global RNA Stabilizers Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America RNA Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe RNA Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific RNA Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.4 South America RNA Stabilizers Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa RNA Stabilizers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 RNA Stabilizers Industry Trends
- 2.2 RNA Stabilizers Industry Drivers
- 2.3 RNA Stabilizers Industry Opportunities and Challenges
- 2.4 RNA Stabilizers Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by RNA Stabilizers Revenue (2021-2026)
- 3.2 Global Top Players by RNA Stabilizers Sales (2021-2026)
- 3.3 Global Top Players by RNA Stabilizers Price (2021-2026)
- 3.4 Global RNA Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global RNA Stabilizers Major Company Production Sites & Headquarters
- 3.6 Global RNA Stabilizers Company, Product Type & Application
- 3.7 Global RNA Stabilizers Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global RNA Stabilizers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025
- 3.8.3 2025 RNA Stabilizers Tier 1, Tier 2, and Tier 3
4 RNA Stabilizers Regional Status and Outlook
- 4.1 Global RNA Stabilizers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global RNA Stabilizers Historic Market Size by Region
- 4.2.1 Global RNA Stabilizers Sales in Volume by Region (2021-2026)
- 4.2.2 Global RNA Stabilizers Sales in Value by Region (2021-2026)
- 4.2.3 Global RNA Stabilizers Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global RNA Stabilizers Forecasted Market Size by Region
- 4.3.1 Global RNA Stabilizers Sales in Volume by Region (2027-2032)
- 4.3.2 Global RNA Stabilizers Sales in Value by Region (2027-2032)
- 4.3.3 Global RNA Stabilizers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 RNA Stabilizers by Application
- 5.1 RNA Stabilizers Market by Application
- 5.1.1 Molecular Biology
- 5.1.2 Genomics
- 5.2 Global RNA Stabilizers Market Size by Application
- 5.2.1 Global RNA Stabilizers Market Size Overview by Application (2021-2032)
- 5.2.2 Global RNA Stabilizers Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global RNA Stabilizers Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America RNA Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe RNA Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific RNA Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.4 South America RNA Stabilizers Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa RNA Stabilizers Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yeasen
- 6.1.1 Yeasen Company Information
- 6.1.2 Yeasen Business Overview
- 6.1.3 Yeasen RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yeasen RNA Stabilizers Product Portfolio
- 6.1.5 Yeasen Recent Developments
- 6.2 YaJi Biological
- 6.2.1 YaJi Biological Company Information
- 6.2.2 YaJi Biological Business Overview
- 6.2.3 YaJi Biological RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 YaJi Biological RNA Stabilizers Product Portfolio
- 6.2.5 YaJi Biological Recent Developments
- 6.3 NCM Biotech
- 6.3.1 NCM Biotech Company Information
- 6.3.2 NCM Biotech Business Overview
- 6.3.3 NCM Biotech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 NCM Biotech RNA Stabilizers Product Portfolio
- 6.3.5 NCM Biotech Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 Vazyme
- 6.5.1 Vazyme Company Information
- 6.5.2 Vazyme Business Overview
- 6.5.3 Vazyme RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Vazyme RNA Stabilizers Product Portfolio
- 6.5.5 Vazyme Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Merck RNA Stabilizers Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Maokangbio
- 6.7.1 Maokangbio Company Information
- 6.7.2 Maokangbio Business Overview
- 6.7.3 Maokangbio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Maokangbio RNA Stabilizers Product Portfolio
- 6.7.5 Maokangbio Recent Developments
- 6.8 Beyotime
- 6.8.1 Beyotime Company Information
- 6.8.2 Beyotime Business Overview
- 6.8.3 Beyotime RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Beyotime RNA Stabilizers Product Portfolio
- 6.8.5 Beyotime Recent Developments
- 6.9 Zymo Research
- 6.9.1 Zymo Research Company Information
- 6.9.2 Zymo Research Business Overview
- 6.9.3 Zymo Research RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Zymo Research RNA Stabilizers Product Portfolio
- 6.9.5 Zymo Research Recent Developments
- 6.10 Takara Bio
- 6.10.1 Takara Bio Company Information
- 6.10.2 Takara Bio Business Overview
- 6.10.3 Takara Bio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Takara Bio RNA Stabilizers Product Portfolio
- 6.10.5 Takara Bio Recent Developments
- 6.11 SRL
- 6.11.1 SRL Company Information
- 6.11.2 SRL Business Overview
- 6.11.3 SRL RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 SRL RNA Stabilizers Product Portfolio
- 6.11.5 SRL Recent Developments
- 6.12 Omega Bio-Tek
- 6.12.1 Omega Bio-Tek Company Information
- 6.12.2 Omega Bio-Tek Business Overview
- 6.12.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
- 6.12.5 Omega Bio-Tek Recent Developments
- 6.13 NZYtech
- 6.13.1 NZYtech Company Information
- 6.13.2 NZYtech Business Overview
- 6.13.3 NZYtech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 NZYtech RNA Stabilizers Product Portfolio
- 6.13.5 NZYtech Recent Developments
- 6.14 New England Biolabs
- 6.14.1 New England Biolabs Company Information
- 6.14.2 New England Biolabs Business Overview
- 6.14.3 New England Biolabs RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 New England Biolabs RNA Stabilizers Product Portfolio
- 6.14.5 New England Biolabs Recent Developments
- 6.15 Genetix Biotech Asia
- 6.15.1 Genetix Biotech Asia Company Information
- 6.15.2 Genetix Biotech Asia Business Overview
- 6.15.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
- 6.15.5 Genetix Biotech Asia Recent Developments
- 6.16 G-Biosciences
- 6.16.1 G-Biosciences Company Information
- 6.16.2 G-Biosciences Business Overview
- 6.16.3 G-Biosciences RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 G-Biosciences RNA Stabilizers Product Portfolio
- 6.16.5 G-Biosciences Recent Developments
- 6.17 Dutscher
- 6.17.1 Dutscher Company Information
- 6.17.2 Dutscher Business Overview
- 6.17.3 Dutscher RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Dutscher RNA Stabilizers Product Portfolio
- 6.17.5 Dutscher Recent Developments
- 6.18 BioEntist
- 6.18.1 BioEntist Company Information
- 6.18.2 BioEntist Business Overview
- 6.18.3 BioEntist RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 BioEntist RNA Stabilizers Product Portfolio
- 6.18.5 BioEntist Recent Developments
7 North America by Country
- 7.1 North America RNA Stabilizers Sales by Country
- 7.1.1 North America RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America RNA Stabilizers Sales by Country (2021-2026)
- 7.1.3 North America RNA Stabilizers Sales Forecast by Country (2027-2032)
- 7.2 North America RNA Stabilizers Market Size by Country
- 7.2.1 North America RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America RNA Stabilizers Market Size by Country (2021-2026)
- 7.2.3 North America RNA Stabilizers Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe RNA Stabilizers Sales by Country
- 8.1.1 Europe RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe RNA Stabilizers Sales by Country (2021-2026)
- 8.1.3 Europe RNA Stabilizers Sales Forecast by Country (2027-2032)
- 8.2 Europe RNA Stabilizers Market Size by Country
- 8.2.1 Europe RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe RNA Stabilizers Market Size by Country (2021-2026)
- 8.2.3 Europe RNA Stabilizers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific RNA Stabilizers Sales by Country
- 9.1.1 Asia-Pacific RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific RNA Stabilizers Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific RNA Stabilizers Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific RNA Stabilizers Market Size by Country
- 9.2.1 Asia-Pacific RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific RNA Stabilizers Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific RNA Stabilizers Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America RNA Stabilizers Sales by Country
- 10.1.1 South America RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America RNA Stabilizers Sales by Country (2021-2026)
- 10.1.3 South America RNA Stabilizers Sales Forecast by Country (2027-2032)
- 10.2 South America RNA Stabilizers Market Size by Country
- 10.2.1 South America RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America RNA Stabilizers Market Size by Country (2021-2026)
- 10.2.3 South America RNA Stabilizers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa RNA Stabilizers Sales by Country
- 11.1.1 Middle East and Africa RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa RNA Stabilizers Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa RNA Stabilizers Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa RNA Stabilizers Market Size by Country
- 11.2.1 Middle East and Africa RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa RNA Stabilizers Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa RNA Stabilizers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 RNA Stabilizers Value Chain Analysis
- 12.1.1 RNA Stabilizers Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 RNA Stabilizers Production Mode & Process
- 12.2 RNA Stabilizers Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 RNA Stabilizers Distributors
- 12.2.3 RNA Stabilizers Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst